Date(s) - March 30, 2022
1:00 pm EDT - 2:00 pm EDT
One of FCF’s partners, the Cancer Research Institute, is holding several events to discuss and explore immunotherapy, which is rapidly becoming the standard of care for many types of cancer.
This webinar will discuss recent advances in immunotherapy clinical trial designs, especially those incorporating novel combinations, that are helping to improve patient experiences and accelerate the development of more cures. Specifically, it will focus on technical improvements making trials more adaptable and efficient, as well as how patient feedback is being incorporated in order to empower them throughout their journey. The event is hosted by CRI’s assistant director of scientific content, Arthur N. Brodsky, Ph.D.
Click here for more information and to register.